Clinuvel Pharmaceuticals
CUV.AX
#7480
Rank
C$0.59 B
Marketcap
C$11.81
Share price
-0.47%
Change (1 day)
13.55%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2024: C$46.96 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are C$58.85 Million. In 2024 the company made an earning of C$46.96 Million, an increase over its 2023 earnings that were of C$42.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024C$46.96 M11.35%
2023C$42.17 M28.31%
2022C$32.87 M22.8%
2021C$26.76 M112.63%
2020C$12.58 M-28.73%
2019C$17.66 M32.79%
2018C$13.3 M75.41%
2017C$7.58 M-332.52%
2016-C$3.27 Million-70.68%
2015-C$11.13 Million53.78%
2014-C$7.24 Million-16.1%
2013-C$8.63 Million-37.92%
2012-C$13.9 Million-18.19%
2011-C$16.98 Million25.31%
2010-C$13.55 Million-21.53%
2009-C$17.27 Million-11.27%
2008-C$19.47 Million80.4%
2007-C$10.79 Million-2.46%
2006-C$11.07 Million-5.35%
2005-C$11.69 Million60.55%
2004-C$7.28 Million97.37%
2003-C$3.69 Million50.62%
2002-C$2.45 Million121.22%
2001-C$1.11 Million254.48%
2000-C$0.32 Million